- Consumer Products
- Latest 131.54
- Currency US$
- Change -4.02
- Percent Change -2.965 %
- Volume 1,502,779
- Fri Mar 7, 2014 04:00 PM EST NASDAQ data delayed 15 minutes.
12 months ended Dec 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Feb 20||$0.77||May 7||$0.37|
12 months ended Mar 08, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Pharmacyclics Inc. is a pharmaceutical company developing products to improve upon therapeutic approaches to cancer, atherosclerosis and retinal disease. The company's products are ring-shaped small molecules called texaphyrins. These patented agents are derived from Pharmacyclics' versatile technology platform for designing and synthesizing energy-potentiating drugs. The texaphyrins localize in cancer cells, atherosclerotic plaque and neovasculature, where they can be activated by forms of energy, including X-rays and light to reduce diseased tissue.
Head OfficePHARMACYCLICS INC 995 E ARQUE